Literature DB >> 18664863

Prevalence of celiac disease in Egyptian children disputes the east-west agriculture-dependent spread of the disease.

M Abu-Zekry1, D Kryszak, M Diab, C Catassi, A Fasano.   

Abstract

OBJECTIVES: Celiac disease (CD) seems to be a common disorder in north Africa; however, to our knowledge no data are yet available on its prevalence in Egypt. This study was undertaken to investigate the frequency of CD in Egyptian children. PATIENTS AND METHODS: We investigated a sample of the general pediatric population (1500 individuals, 656 girls and 844 boys, age range 7 months to 18 years, median age 8.0 years) (group A); 150 children (age range 6 months to 13 years, median age 16 months) admitted for diarrhea or failure to thrive (group B); and 250 children and adolescents with type 1 diabetes (group C). The screening test was serum class A anti-transglutaminase (anti-tTG) antibody; immunoglobulin A (IgA) antiendomysium, total IgA, and IgG anti-tTG, and small bowel biopsy was performed for confirmation of diagnosis.
RESULTS: In group A, 8 of 1500 children fulfilled the criteria for CD diagnosis; the prevalence of CD was at least 1 in 187 individuals (0.53%; 95% CI 0.17%-0.89%). In group B, 7 of 150 children had CD (4.7%, 95% CI 1.4-7.9). In group C, 16 of 250 sera showed positive results to both the IgA anti-tTG and the IgA antiendomysium test (6.4%; 95% CI 3.4-9.4).
CONCLUSIONS: Celiac disease is a frequent disorder among Egyptian children, both in the general population and in at-risk groups. Therefore, our data do not support the theory of a Middle East-Europe CD prevalence gradient secondary to the pattern of agriculture spreading from the so-called Fertile Crescent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18664863     DOI: 10.1097/MPG.0b013e31815ce5d1

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  26 in total

1.  Celiac disease: a challenge for all physicians.

Authors:  Srihari Mahadov; Peter H R Green
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-08

Review 2.  Celiac disease in Middle Eastern and North African countries: a new burden?

Authors:  Kassem Barada; Abbas Bitar; Mohamad Abdul-Razak Mokadem; Jana Ghazi Hashash; Peter Green
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

3.  Etiological factors of short stature in children and adolescents: experience at a tertiary care hospital in Egypt.

Authors:  Almontaser Hussein; Hekma Farghaly; Eman Askar; Kotb Metwalley; Khaled Saad; Asmaa Zahran; Hisham A Othman
Journal:  Ther Adv Endocrinol Metab       Date:  2017-05-03       Impact factor: 3.565

4.  Profound Reversible Hypogammaglobulinemia Caused by Celiac Disease in the Absence of Protein Losing Enteropathy.

Authors:  Rohan Ameratunga; Russell William Barker; Richard Henderson Steele; Maneka Deo; See-Tarn Woon; Mee Ling Yeong; Wikke Koopmans
Journal:  J Clin Immunol       Date:  2015-08-29       Impact factor: 8.317

5.  The evolution of celiac disease publications: a holistic approach with bibliometric analysis.

Authors:  Emre Demir; Atakan Comba
Journal:  Ir J Med Sci       Date:  2019-08-17       Impact factor: 1.568

6.  Celiac disease in oman: a tertiary centre experience.

Authors:  Tawfiq Taki Al-Lawati; Hashim Sadiq Al-Musawi
Journal:  Oman Med J       Date:  2013-01

7.  A limp in a pregnant woman as a first presentation of celiac disease.

Authors:  A A Jammah
Journal:  Osteoporos Int       Date:  2011-05-25       Impact factor: 4.507

Review 8.  Celiac disease in children and adolescents: special considerations.

Authors:  Kimberly P Newton; Shereen A Singer
Journal:  Semin Immunopathol       Date:  2012-05-02       Impact factor: 9.623

Review 9.  Epidemiology and clinical presentations of celiac disease.

Authors:  Norelle Rizkalla Reilly; Peter H R Green
Journal:  Semin Immunopathol       Date:  2012-04-24       Impact factor: 9.623

Review 10.  Celiac disease.

Authors:  Alberto Rubio-Tapia; Joseph A Murray
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.